Tango Therapeutics (TNGX) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.37
-0.33
-0.3
-0.27

Details

Expected EPS
-0.34375
Actual EPS
-0.35
Surprise EPS
-0.01
Surprise Percent
+1.82%

Description

Tango Therapeutics (TNGX) has reported earnings of -0.35 per share for Q3 2025.

0 Comments

Share your thoughts